Smallpox: residual antibody after vaccination.
نویسندگان
چکیده
Of all the microorganisms and toxins, poxviruses (Orthopoxvirus) have the greatest potential for use by terrorists. These viruses can spread rapidly through the environment following initial infection. In 1980, the World Health Organization Eradication Program discontinued vaccination for smallpox and declared that the disease had been eliminated. With the threat of smallpox virus as a bioterrorism weapon, questions have been asked about the persistence of protection (as offered by antibodies) following vaccination with vaccinia virus vaccine. To address this, sera from 204 adults vaccinated as children were tested by enzyme immunoassay (EIA) for the presence of vaccinia virus antibody. Of the 204 individuals whose sera were examined for the presence of vaccinia antibody, 165 (80.9%) had been vaccinated once and 39 (19.1%) had been vaccinated at least twice. Of the 165 sera from individuals vaccinated once, 112 (67.9%) were positive. Of the 39 sera from individuals vaccinated more than once, 31 (79.5%) were positive. The presence of a vaccination scar at the time of blood collection was not determined. Fifty-six nonvaccinated individuals, under 30 years of age, were tested by EIA; four of these (7.1%) were positive for vaccinia virus antibody by EIA. Forty-four EIA-positive and 16 EIA-negative sera were also tested by serum neutralization (SN) as a comparison with the EIA test results; one serum (negative by EIA) was SN positive. No attempt was made to ascertain any demographics other than age (date of birth) and "remembered" times of vaccination.
منابع مشابه
Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.
BACKGROUND Intradermal skin testing with inactivated vaccinia virus was evaluated for its prediction of residual immunity to smallpox. METHODS An intradermal skin test was performed with heat-inactivated Lancy-Vaxina. Two days later, the subjects were vaccinated with Lancy-Vaxina. The skin lesions resulting from this vaccination were used as a surrogate marker of residual immunity to smallpox...
متن کاملFailure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after.
Successful vaccination against smallpox with conventional vaccinia virus is usually determined by the development of a vesicular skin lesion at the site of vaccinia inoculation, called a "take." Although previous vaccination is known to be associated with attenuation of the take, the immunology that underlies a no-take in vaccinia-naïve individuals is not well understood. We hypothesized that a...
متن کاملAntibody response following smallpox vaccination and revaccination.
The measurement of antibody following vaccination has been recorded in many publications. The inhibition of vaccinia haemagglutinin, because of its technical simplicity, is a method which has been commonly employed in recent years, although the complement-fixation and neutralization techniques have also been used. Some kind of neutralization test is believed to give a better measure of protecti...
متن کاملAntiviral immunity following smallpox virus infection: a case-control study.
Outbreaks of smallpox (i.e., caused by variola virus) resulted in up to 30% mortality, but those who survived smallpox infection were regarded as immune for life. Early studies described the levels of neutralizing antibodies induced after infection, but smallpox was eradicated before contemporary methods for quantifying T-cell memory were developed. To better understand the levels and duration ...
متن کاملFrequency of Revaccination against Smallpox
extending the time for revaccination beyond 10 years may be based on insufficient and conflicting evidence of persistence of immunity (1,2). The evidence that cellmediated immunity and neutralizing antibody persist after one vaccination is conflicting (2–5). This residual immunity is often low, and its protective activity in vivo is unclear. Similarly, in vivo reports of durable immunity to sma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of clinical microbiology
دوره 41 9 شماره
صفحات -
تاریخ انتشار 2003